Warning on drug-resistant gonorrhoea

A global warning has been issued about increasing rates of antibiotic resistant gonorrhoea.

Rates of the disease are increasing – while the bacteria are evolving to resist every new class of antibiotics, according to the World Health Organisation.

There is resistance against the last resort treatments – extended-spectrum cephalosporins oral cefixime and injectable ceftriaxone – and this has been reported in 66% of countries, WHO warned.

WHO said there are only three drug candidates under clinical development.

The organisation has reported its concerns in a special supplement of PLoS Medicine ahead of the World Congress on STI and HIV in Rio de Janeiro, Brazil, next week.

WHO director of antimicrobial resistance Dr Marc Sprenger said: “To control gonorrhoea, we need new tools and systems for better prevention, treatment, earlier diagnosis, and more complete tracking and reporting of new infections, antibiotic use, resistance and treatment failures.

“Specifically, we need new antibiotics, as well as rapid, accurate, point-of-care diagnostic tests—ideally, ones that can predict which antibiotics will work on that particular infection—and longer term, a vaccine to prevent gonorrhoea.”

PLoS Medicine 6 July 2017 [abstract]

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index